Browsing Tag
Hailie Smartinhaler
1 post
Adherium (ASX: ADR) turns pilot into performance with RPM success across Allergy Partners
Adherium’s RPM expansion through Allergy Partners hits a key milestone in the U.S., but will 4,000 patients be enough to lift its ASX share price from record lows?